Narrative review / 2015
Newer weight management medications aid weight loss and maintenance, with varying positive and potentially negative cardiometabolic effects.
Since the 1980s, obesity prevalence has nearly doubled globally, with treatments including lifestyle modification, medications, and surgery. This review discusses the mechanisms and cardiometabolic implications of newly approved next-generation weight management medications. These medications demonstrate efficacy in initial weight management and long-term maintenance, while showing varying effects on diabetes and cardiovascular risks.
- Study type
- Narrative review
- Who was studied
- Individuals with obesity
- What was measured
- Weight management, diabetes risk, and cardiovascular disease risk
THE PAPER
Next generation of weight management medications: implications for diabetes and CVD risk.
Wharton S, Serodio KJ. Curr Cardiol Rep, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.